CD274 and urothelial carcinoma: Avelumab: 1) Fully human monoclonal IgG1 antibody against PD-L1; 2) Fc component intact, capable of inducing ADCC; 3) The US FDA approved for Merkel cell carcinoma and urothelial carcinoma; 4) Well tolerated across many solid tumor types.